Literature DB >> 3091507

Recombinant human gamma interferon inhibits simian malaria.

R K Maheshwari, C W Czarniecki, G P Dutta, S K Puri, B N Dhawan, R M Friedman.   

Abstract

Prophylactic treatment with 0.1 mg of human gamma interferon per kg (body weight) per day completely suppressed experimental infection with Plasmodium cynomolgi B sporozoites in rhesus monkeys. Treatment with lower doses partially suppressed this infection. Prophylactic treatment with human gamma interferon, however, had no protective effect against trophozoite-induced infection, suggesting that the interferon effect was limited to the exoerythrocytic stage of parasitic development.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3091507      PMCID： PMC260838          DOI： 10.1128/iai.53.3.628-630.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

1.  Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii).

Authors:  J S Remington; T C Merigan
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

2.  Role of interferon in experimental mouse malaria.

Authors:  W W Schultz; K Y Huang; F B Gordon
Journal:  Nature       Date:  1968-11-16       Impact factor: 49.962

3.  Anti-malarial effect of interferon inducers at different stages of development of Plasmodium berghei in the mouse.

Authors:  R I Jahiel; R S Nussenzweig; J Vanderberg; J Vilcek
Journal:  Nature       Date:  1968-11-16       Impact factor: 49.962

4.  Exogenous interferon protects mice against Plasmodium berghei malaria.

Authors:  R I Jahiel; J Vilcek; R S Nussenzweig
Journal:  Nature       Date:  1970-09-26       Impact factor: 49.962

5.  Human interferon as a therapeutic agent.

Authors:  T C Merigan
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

6.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

8.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

Authors:  R Kurzrock; M G Rosenblum; S A Sherwin; A Rios; M Talpaz; J R Quesada; J U Gutterman
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

10.  Cloned mouse interferon-gamma inhibits the growth of Rickettsia prowazekii in cultured mouse fibroblasts.

Authors:  J Turco; H H Winkler
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307
View more
  28 in total

1.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis.

Authors:  Brandon M Boyce; Brock A Lindsey; Nina B Clovis; E Suzanne Smith; Gerald R Hobbs; David F Hubbard; Sanford E Emery; John B Barnett; Bingyun Li
Journal:  J Orthop Res       Date:  2011-08-03       Impact factor: 3.494

3.  Gamma interferon controls Eimeria vermiformis primary infection in BALB/c mice.

Authors:  M E Rose; D Wakelin; P Hesketh
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 4.  Animal models in interferon research: some current trends.

Authors:  H Schellekens
Journal:  Experientia       Date:  1989-06-15

5.  CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.

Authors:  W R Weiss; M Sedegah; R L Beaudoin; L H Miller; M F Good
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.

Authors:  J P Sauzet; B L Perlaza; K Brahimi; P Daubersies; P Druilhe
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa.

Authors:  A Ishih; T Nagata; F Kobayashi; T Miyase; M Terada
Journal:  Parasitol Res       Date:  2004-08-26       Impact factor: 2.289

8.  Tomatine adjuvantation of protective immunity to a major pre-erythrocytic vaccine candidate of malaria is mediated via CD8+ T cell release of IFN-gamma.

Authors:  Karen G Heal; Andrew W Taylor-Robinson
Journal:  J Biomed Biotechnol       Date:  2010-03-11

9.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Class II-restricted protective immunity induced by malaria sporozoites.

Authors:  Giane A Oliveira; Kota Arun Kumar; J Mauricio Calvo-Calle; Caroline Othoro; David Altszuler; Victor Nussenzweig; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.